デフォルト表紙
市場調査レポート
商品コード
1391130

持続血糖モニタリングの世界市場レポート 2024年

Continous Blood Glucose Monitoring Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
持続血糖モニタリングの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

病院の急増は、持続血糖モニタリング市場の拡大に貢献すると考えられています。医療や外科治療を専門に行う病院では、特に糖尿病患者やグルコース関連合併症のリスクがある患者の血糖値を正確かつ継続的にモニタリングするために、持続血糖モニタリングが極めて重要であると考えられています。2023年9月のDiscovery Therapyによると、米国には2021年に約6,090の病院があったが、世界全体では約16万5,000の病院があっています。また、2023年5月の米国病院協会の報告によると、2022年のアメリカの病院数は6,129でした。世界の病院数の増加は、持続血糖モニタリング市場の成長を促進すると予想されます。

2023年の持続血糖モニタリング市場では北米が最大地域でした。持続血糖モニタリング市場レポートでカバーされている地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 持続血糖モニタリング市場の特徴

第3章 持続血糖モニタリング市場の動向と戦略

第4章 持続血糖モニタリング市場-マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の持続血糖モニタリング市場規模と成長

  • 世界の持続血糖モニタリング市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の持続血糖モニタリングの市場規模実績と成長、2018~2023年
  • 世界の持続血糖モニタリング市場規模と成長予測、2023~2028年、2033年

第6章 持続血糖モニタリング市場セグメンテーション

  • 世界の持続血糖モニタリング市場、部品別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • インスリンポンプ
  • センサー
  • 送信機
  • 受信機
  • 世界の持続血糖モニタリング市場、用途別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • 1型糖尿病患者
  • 2型糖尿病患者
  • 妊娠糖尿病
  • 救命救急患者
  • 世界の持続血糖モニタリング市場、エンドユーザー別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • 病院
  • 在宅医療診断
  • その他のエンドユーザー

第7章 持続血糖モニタリング市場の地域および国分析

  • 世界の持続血糖モニタリング市場、地域別、実績および予測、2018~2023年、2023~2028年、2033年
  • 世界の持続血糖モニタリング市場、国別、実績および予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋の持続血糖モニタリング市場

第9章 中国の持続血糖モニタリング市場

第10章 インドの持続血糖モニタリング市場

第11章 日本の持続血糖モニタリング市場

第12章 オーストラリアの持続血糖モニタリング市場

第13章 インドネシアの持続血糖モニタリング市場

第14章 韓国の持続血糖モニタリング市場

第15章 西欧の持続血糖モニタリング市場

第16章 英国の持続血糖モニタリング市場

第17章 ドイツの持続血糖モニタリング市場

第18章 フランスの持続血糖モニタリング市場

第19章 イタリアの持続血糖モニタリング市場

第20章 スペインの持続血糖モニタリング市場

第21章 東欧の持続血糖モニタリング市場

第22章 ロシアの持続血糖モニタリング市場

第23章 北米の持続血糖モニタリング市場

第24章 米国の持続血糖モニタリング市場

第25章 カナダの持続血糖モニタリング市場

第26章 南米の持続血糖モニタリング市場

第27章 ブラジルの持続血糖モニタリング市場

第28章 中東の持続血糖モニタリング市場

第29章 アフリカの持続血糖モニタリング市場

第30章 持続血糖モニタリング市場の競合情勢と企業プロファイル

  • 持続血糖モニタリング市場の競合情勢
  • 持続血糖モニタリング市場の企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Lifescan Inc.
    • Medtronic plc.
    • Abbott Laboratories
    • GlySens Inc.

第31章 世界の持続血糖モニタリング市場の競合ベンチマーキング

第32章 世界の持続血糖モニタリング市場の競合ダッシュボード

第33章 持続血糖モニタリング市場における主要な合併と買収

第34章 持続血糖モニタリング市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r9490

“Continuous Blood Glucose Monitoring Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous blood glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous blood glucose monitoring? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The continuous blood glucose monitoring market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Component: Insulin Pumps; Sensors; Transmitters; Receivers
  • 2) By Application: Type 1 Diabetic Patients; Type 2 Diabetic Patients; Gestational Diabetes; Critical Care Patients
  • 3) By End User: Hospitals; Homecare Diagnostics; Other End Users
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Lifescan Inc.; Medtronic plc.; Abbott Laboratories; GlySens Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A continuous blood glucose monitoring device plays a crucial role in helping individuals better regulate glucose levels throughout the day, leading to fewer instances of low blood glucose situations.

The main components in continuous blood glucose monitoring devices include insulin pumps, sensors, transmitters, and receivers. Insulin pumps are compact, computerized devices that are programmed to administer pre-determined doses of insulin at specific intervals. These devices are particularly utilized by individuals with type 1 diabetes, type 2 diabetes, gestational diabetes, and critical care patients. The end-users for continuous blood glucose monitoring devices include hospitals, homecare diagnostics, and various other settings.

The continuous blood glucose monitoring market research report is one of a series of new reports from The Business Research Company that provides continuous blood glucose monitoring market statistics, including continuous blood glucose monitoring industry global market size, regional shares, competitors with a continuous blood glucose monitoring market share, detailed continuous blood glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous blood glucose monitoring industry. This continuous blood glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continous blood glucose monitoring market size has grown rapidly in recent years. It will grow from $8.09 in 2023 to $9.68 in 2024 at a compound annual growth rate (CAGR) of 19.7%. The growth observed in the historical period in the continuous blood glucose monitoring device market can be attributed to several factors, including the increase in diabetes prevalence, growing regulatory compliance, the demand for remote monitoring solutions, expansion into emerging markets, and a rise in healthcare spending. These factors collectively contributed to the expansion and adoption of continuous blood glucose monitoring devices during that time, reflecting the increasing need for effective solutions in managing diabetes and related conditions.

The continous blood glucose monitoring market size is expected to see exponential growth in the next few years. It will grow to $20.44 in 2028 at a compound annual growth rate (CAGR) of 20.5%. The anticipated growth in the forecast period in the continuous blood glucose monitoring device market can be attributed to various factors, including the growing aging population, the expansion of home healthcare services, the rise in telehealth services, increased healthcare expenditure, and a general rise in disposable income. Major trends expected during this period include the integration of wearable technologies, the incorporation of artificial intelligence and machine learning, advancements in sensor technology for enhanced accuracy, and increased partnerships and collaborations within the healthcare industry. These trends collectively indicate a dynamic and evolving landscape in continuous blood glucose monitoring, reflecting advancements in technology and collaborative efforts to improve healthcare outcomes.

The continuous blood glucose monitoring market is anticipated to experience growth, propelled by the increasing prevalence of diabetes. Diabetes, a health condition characterized by fluctuating blood glucose levels, can benefit significantly from the use of blood glucose monitoring devices. These devices aid in detecting trends and patterns, offering a comprehensive view of a diabetic individual's condition. The International Diabetes Federation (IDF) reported in its IDF Diabetes Atlas 10th edition in July 2021 that the estimated global population of individuals living with diabetes is projected to reach 643 million by 2030 and further increase to 783 million by 2045. This rise, from approximately 537 million adults in 2021, highlights the escalating prevalence of diabetes as a driving force behind the continuous blood glucose monitoring market's growth.

The proliferation of hospitals is poised to contribute to the expansion of the continuous blood glucose monitoring market. Hospitals, dedicated to providing medical or surgical treatment, find continuous blood glucose monitoring crucial for precise and ongoing monitoring of blood glucose levels, particularly for patients with diabetes or those at risk of glucose-related complications. According to Discovery Therapy in September 2023, the US had around 6,090 hospitals in 2021, while globally, there were approximately 165,000 hospitals. Additionally, the American Hospital Association reported in May 2023 that there were 6,129 hospitals in America in 2022. The increased number of hospitals globally is expected to drive the growth of the continuous blood glucose monitoring market.

Technological advancements emerge as a significant trend shaping the continuous blood glucose monitoring market. Key players in the market are actively engaged in developing advanced technological solutions to enhance their market presence. In 2021, Philips, a Netherlands-based health technology company specializing in glucose monitoring devices, launched non-invasive monitors for COPD patients based on ExpiraFlow technology. These non-invasive monitors enable healthcare professionals to detect and screen expiratory flow limitations, offering a valuable tool for optimal home care therapy. This focus on technological innovation underscores the commitment of major companies to staying at the forefront of the continuous blood glucose monitoring market.

Prominent companies in the diabetes care devices market are actively pursuing innovation with the introduction of new products, exemplified by the Medtronic Extended infusion set, aimed at enhancing their profitability. The Medtronic Extended infusion set is a tubing system designed to deliver insulin from the pump to the body and boasts a wear duration of up to 7 days. Medtronic Plc., a US-based medical equipment manufacturer, launched this product in select European countries in April 2021. Initially available for purchase in specific European nations, including Finland and Belgium, the product is set for a gradual rollout to additional European countries. The Medtronic Extended infusion set includes an all-in-one serter, streamlining the process of changing the set and making it fast and straightforward. Notably, its innovative technology and alternative materials allow for double the wear duration compared to other Medtronic infusion sets, typically approved for 2-3 days of use.

In a strategic move in May 2023, Medtronic PLC., an Ireland-based medical device company, acquired EOFlow for an undisclosed amount. This acquisition is geared towards strengthening Medtronic's diabetes product portfolio and expanding its capacity to offer comprehensive support to a larger global community managing diabetes, all within a unified Medtronic ecosystem. EOFlow Co. Ltd., based in South Korea, is recognized for manufacturing the insulin patch pump EOPatch. This strategic acquisition aligns with Medtronic's commitment to continuous growth and innovation in the diabetes care devices market.

Major companies operating in the continous blood glucose monitoring market include F. Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Goldsite Diagnostics Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini Diagnostics, Echo Therapeutics Inc., Johnson & Johnson Services Inc., Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies Inc., Texas Instruments Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality, Nemotecnia S.A.

North America was the largest region in the continuous blood glucose monitoring market in 2023. The regions covered in the continuous blood glucose monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the continuous blood glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The continuous blood glucose monitoring market consists of sales of real-time continuous glucose monitoring, and intermittently scanned continuous glucose monitoring. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Continuous Blood Glucose Monitoring Market Characteristics

3. Continuous Blood Glucose Monitoring Market Trends And Strategies

4. Continuous Blood Glucose Monitoring Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Continuous Blood Glucose Monitoring Market Size and Growth

  • 5.1. Global Continuous Blood Glucose Monitoring Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Continuous Blood Glucose Monitoring Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Continuous Blood Glucose Monitoring Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Continuous Blood Glucose Monitoring Market Segmentation

  • 6.1. Global Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Insulin Pumps
  • Sensors
  • Transmitters
  • Receivers
  • 6.2. Global Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Type 1 Diabetic Patients
  • Type 2 Diabetic Patients
  • Gestational Diabetes
  • Critical Care Patients
  • 6.3. Global Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare Diagnostics
  • Other End Users

7. Continuous Blood Glucose Monitoring Market Regional And Country Analysis

  • 7.1. Global Continuous Blood Glucose Monitoring Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Continuous Blood Glucose Monitoring Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Continuous Blood Glucose Monitoring Market

  • 8.1. Asia-Pacific Continuous Blood Glucose Monitoring Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Continuous Blood Glucose Monitoring Market

  • 9.1. China Continuous Blood Glucose Monitoring Market Overview
  • 9.2. China Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Continuous Blood Glucose Monitoring Market

  • 10.1. India Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Continuous Blood Glucose Monitoring Market

  • 11.1. Japan Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Continuous Blood Glucose Monitoring Market

  • 12.1. Australia Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Continuous Blood Glucose Monitoring Market

  • 13.1. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Continuous Blood Glucose Monitoring Market

  • 14.1. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Continuous Blood Glucose Monitoring Market

  • 15.1. Western Europe Continuous Blood Glucose Monitoring Market Overview
  • 15.2. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Continuous Blood Glucose Monitoring Market

  • 16.1. UK Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Continuous Blood Glucose Monitoring Market

  • 17.1. Germany Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Continuous Blood Glucose Monitoring Market

  • 18.5. France Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Continuous Blood Glucose Monitoring Market

  • 19.9. Italy Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Continuous Blood Glucose Monitoring Market

  • 20.13. Spain Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Continuous Blood Glucose Monitoring Market

  • 21.1. Eastern Europe Continuous Blood Glucose Monitoring Market Overview
  • 21.2. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Continuous Blood Glucose Monitoring Market

  • 22.1. Russia Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Continuous Blood Glucose Monitoring Market

  • 23.1. North America Continuous Blood Glucose Monitoring Market Overview
  • 23.2. North America Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Continuous Blood Glucose Monitoring Market

  • 24.1. USA Continuous Blood Glucose Monitoring Market Overview
  • 24.2. USA Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Continuous Blood Glucose Monitoring Market

  • 25.1. Canada Continuous Blood Glucose Monitoring Market Overview
  • 25.2. Canada Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Continuous Blood Glucose Monitoring Market

  • 26.1. South America Continuous Blood Glucose Monitoring Market Overview
  • 26.2. South America Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Continuous Blood Glucose Monitoring Market

  • 27.1. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Continuous Blood Glucose Monitoring Market

  • 28.1. Middle East Continuous Blood Glucose Monitoring Market Overview
  • 28.2. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Continuous Blood Glucose Monitoring Market

  • 29.1. Africa Continuous Blood Glucose Monitoring Market Overview
  • 29.2. Africa Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Continuous Blood Glucose Monitoring Market Competitive Landscape And Company Profiles

  • 30.1. Continuous Blood Glucose Monitoring Market Competitive Landscape
  • 30.2. Continuous Blood Glucose Monitoring Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Lifescan Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlySens Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Continuous Blood Glucose Monitoring Market Competitive Benchmarking

32. Global Continuous Blood Glucose Monitoring Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Continuous Blood Glucose Monitoring Market

34. Continuous Blood Glucose Monitoring Market Future Outlook and Potential Analysis

  • 34.1 Continuous Blood Glucose Monitoring Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Continuous Blood Glucose Monitoring Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Continuous Blood Glucose Monitoring Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer